Cofactor squelching: Artifact or fact?

BioEssays

Volumn 38, Issue 7, 2016, Pages 618-626

  Schmidt, Søren Fisker ^a   Larsen, Bjørk Ditlev ^a   Loft, Anne ^a   Mandrup, Susanne ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

ChIP seq; cofactor redistribution; cofactor squelching; super enhancers; transcriptional repression

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RNA POLYMERASE II; ROSIGLITAZONE; THYMIDINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; COFACTOR SQUELCHING; ENHANCER REGION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; MAMMAL CELL; PROTEIN BINDING; RECEPTOR BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 84976603170     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201600034     Document Type: Article

References (79)

1. Sainsbury S, Bernecky C, Cramer P. 2015. Structural basis of transcription initiation by RNA polymerase II. Nat Rev Mol Cell Biol 16: 129–43.
2. Venkatesh S, Workman JL. 2015. Histone exchange, chromatin structure and the regulation of transcription. Nat Rev Mol Cell Biol 16: 178–89.
3. Jonkers I, Lis JT. 2015. Getting up to speed with transcription elongation by RNA polymerase II. Nat Rev Mol Cell Biol 16: 167–77.
4. Voss TC, Hager GL. 2014. Dynamic regulation of transcriptional states by chromatin and transcription factors. Nat Rev Genet 15: 69–81.
5. Evans RM, Mangelsdorf DJ. 2014. Nuclear receptors, RXR, and the big bang. Cell 157: 255–66.
6. Pascual G, Glass CK. 2006. Nuclear receptors versus inflammation: mechanisms of transrepression. Trends Endocrinol Metab 17: 321–7.
7. Glass CK, Saijo K. 2010. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol 10: 365–76.
8. Perissi V, Jepsen K, Glass CK, Rosenfeld MG. 2010. Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet 11: 109–23.
9. Surjit M, Ganti KP, Mukherji A, Ye T, et al. 2011. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145: 224–41.
10. Hudson WH, Youn C, Ortlund EA. 2013. The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol 20: 53–8.
11. Uhlenhaut NH, Barish GD, Yu RT, Downes M, et al. 2013. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol Cell 49: 158–71.
12. Gill G, Ptashne M. 1988. Negative effect of the transcriptional activator GAL4. Nature 334: 721–4.
13. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, et al. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57: 433–42.
14. Prywes R, Zhu H. 1992. In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activators. Nucleic Acids Res 20: 513–20.
15. Zhu H, Joliot V, Prywes R. 1994. Role of transcription factor TFIIF in serum response factor-activated transcription. J Biol Chem 269: 3489–97.
16. Zhu H, Pyrwes R. 1992. Identification of a coactivator that increases activation of transcription by serum response factor and GAL4-VP16 in vitro. Proc Natl Acad Sci USA 89: 5291–5.
17. Liu X, Berk AJ. 1995. Reversal of in vitro p53 squelching by both TFIIB and TFIID. Mol Cell Biol 15: 6474–8.
18. Ptashne M. 1988. How eukaryotic transcriptional activators work. Nature 335: 683–9.
19. Sadowski I, Ma J, Triezenberg S, Ptashne M. 1988. GAL4-VP16 is an unusually potent transcriptional activator. Nature 335: 563–4.
20. Berger SL, Cress WD, Cress A, Triezenberg SJ, et al. 1990. Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors. Cell 61: 1199–208.
21. Kamei Y, Xu L, Heinzel T, Torchia J, et al. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403–14.
22. Fronsdal K, Engedal N, Slagsvold T, Saatcioglu F. 1998. CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem 273: 31853–9.
23. Kelleher RJ, 3rd, Flanagan PM, Kornberg RD. 1990. A novel mediator between activator proteins and the RNA polymerase II transcription apparatus. Cell 61: 1209–15.
24. Flanagan PM, Kelleher RJ, 3rd, Sayre MH, Tschochner H, et al. 1991. A mediator required for activation of RNA polymerase II transcription in vitro. Nature 350: 436–8.
25. Pugh BF, Tjian R. 1990. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 61: 1187–97.
26. Furey TS. 2012. ChIP-seq and beyond: new and improved methodologies to detect and characterize protein-DNA interactions. Nat Rev Genet 13: 840–52.
27. Rauch A, Mandrup S. 2016. A Genome-Wide perspective on metabolism. Handb Exp Pharmacol 233:1–28.
28. Consortium EP. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57–74.
29. Moorman C, Sun L, Wang J, de Wit E, et al. 2006. Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster. Proc Nat Acad Sci USA 103: 12027–32.
30. Chen X, Xu H, Yuan P, Fang F, et al. 2008. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133: 1106–17.
31. Boergesen M, Pedersen T, Gross B, van Heeringen S, et al. 2012. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites. Mol Cell Biol 32: 852–67.
32. Gerstein M, Kundaje A, Hariharan M, Landt S, et al. 2012. Architecture of the human regulatory network derived from ENCODE data. Nature 489: 91–100.
33. Siersbæk R, Nielsen R, John S, Sung M-H, et al. 2011. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J 30: 1459–72.
34. Mod EC, Roy S, Ernst J, Kharchenko PV, et al. 2010. Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science 330: 1787–97.
35. Gerstein MB, Lu ZJ, Van Nostrand EL, Cheng C, et al., 2010. Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project. Science 330: 1775–87.
36. Siersbaek R, Rabiee A, Nielsen R, Sidoli S, et al. 2014. Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell Rep 7: 1443–55.
37. Grosveld F, van Assendelft GB, Greaves DR, Kollias G. 1987. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51: 975–85.
38. Collis P, Antoniou M, Grosveld F. 1990. Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J 9: 233–40.
39. Parker SC, Stitzel ML, Taylor DL, Orozco JM, et al. 2013. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Nat Acad Sci USA 110: 17921–6.
40. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, et al. 2013. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153: 307–19.
41. Loven J, Hoke HA, Lin CY, Lau A, et al. 2013. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320–34.
42. Hnisz D, Abraham BJ, Lee TI, Lau A, et al. 2013. Super-enhancers in the control of cell identity and disease. Cell 155: 934–47.
43. Loft A, Forss I, Siersbaek MS, Schmidt SF, et al. 2015. Browning of human adipocytes requires KLF11 and reprogramming of PPARgamma superenhancers. Genes Dev 29: 7–22.
44. Saint-Andre V, Federation AJ, Lin CY, Abraham BJ, et al. 2016. Models of human core transcriptional regulatory circuitries. Genome Res 26: 385–96.
45. Brown JD, Lin CY, Duan Q, Griffin G, et al. 2014. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell 56: 219–31.
46. Hnisz D, Schuijers J, Lin CY, Weintraub AS, et al. 2015. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell 58: 362–70.
47. Ing-Simmons E, Seitan VC, Faure AJ, Flicek P, et al. 2015. Spatial enhancer clustering and regulation of enhancer-proximal genes by cohesin. Genome Res 25: 504–13.
48. Guertin MJ, Zhang X, Coonrod SA, Hager GL. 2014. Transient estrogen receptor binding and p300 redistribution support a squelching mechanism for estradiol-repressed genes. Mol Endocrinol 28: 1522–33.
49. He HH, Meyer CA, Chen MW, Jordan VC, et al. 2012. Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res 22: 1015–25.
50. Step SE, Lim HW, Marinis JM, Prokesch A, et al. 2014. Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARgamma-driven enhancers. Genes Dev 28: 1018–28.
51. Schmidt SF, Larsen BD, Loft A, Nielsen R, et al. 2015. Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers. Genome Res 25: 1281–94.
52. Teytelman L, Thurtle DM, Rine J, van Oudenaarden A. 2013. Highly expressed loci are vulnerable to misleading ChIP localization of multiple unrelated proteins. Proc Nat Acad Sci USA 110: 18602–7.
53. Jain D, Baldi S, Zabel A, Straub T, et al. 2015. Active promoters give rise to false positive 'Phantom Peaks' in ChIP-seq experiments. Nucleic Acids Res 43: 6959–68.
54. Yang WR, Wang Y, Zhang JJ, Zhang JH, et al. 2015. MTOR is involved in 17beta-estradiol-induced, cultured immature boar Sertoli cell proliferation via regulating the expression of SKP2, CCND1, and CCNE1. Mol Reprod Dev 82: 305–14.
55. Divakaruni AS, Wiley SE, Rogers GW, Andreyev AY, et al. 2013. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc Natl Acad Sci USA 110: 5422–7.
56. Giniger E, Ptashne M. 1988. Cooperative DNA binding of the yeast transcriptional activator GAL4. Proc Nat Acad Sci USA 85: 382–6.
57. Griggs DW, Johnston M. 1991. Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression. Proc Nat Acad Sci USA 88: 8597–601.
58. Hah N, Benner C, Chong LW, Yu RT, et al. 2015. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc Nat Acad Sci USA 112: E297–302.
59. De Bosscher K, Vanden Berghe W, Haegeman G. 2001. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol Endocrinol 15: 219–27.
60. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, et al. 2000. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Nat Acad Sci USA 97: 3919–24.
61. Cheng AW, Wang H, Yang H, Shi L, et al. 2013. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res 23: 1163–71.
62. Sternberg SH, Doudna JA. 2015. Expanding the biologist's toolkit with CRISPR-Cas9. Mol Cell 58: 568–74.
63. Madsen JG, Schmidt SF, Larsen BD, Loft A, et al. 2015. IRNA-seq: computational method for genome-wide assessment of acute transcriptional regulation from total RNA-seq data. Nucleic Acids Res 43: e40.
64. Wallerman O, Nord H, Bysani M, Borghini L, et al. 2015. LobChIP: from cells to sequencing ready ChIP libraries in a single day. Epigenetics Chromatin 8: 25.
65. Lara-Astiaso D, Weiner A, Lorenzo-Vivas E, Zaretsky I, et al. 2014. Immunogenetics. Chromatin state dynamics during blood formation. Science 345: 943–9.
66. Moyerbrailean GA, Davis GO, Harvey CT, Watza D, et al. 2015. A high-throughput RNA-seq approach to profile transcriptional responses. Sci Rep 5: 14976.
67. Tsompana M, Valiyaparambil S, Bard J, Marzullo B, et al. 2015. An automated method for efficient, accurate and reproducible construction of RNA-seq libraries. BMC Res Notes 8: 124.
68. Berguet G, Hendrickx J, Sabatel C, Laczik M, et al. 2014. Automating ChIP-seq experiments to generate epigenetic profiles on 10, 000 HeLa cells. J Vis Exp e52150. doi:10.3791/52150
69. Kang S, Tsai LT, Zhou Y, Evertts A, et al. 2015. Identification of nuclear hormone receptor pathways causing insulin resistance by transcriptional and epigenomic analysis. Nature Cell Biol 17: 44–56.
70. Ryden M, Dicker A, van Harmelen V, Hauner H, et al. 2002. Mapping of early signaling events in tumor necrosis factor-alpha −mediated lipolysis in human fat cells. J Biol Chem 277: 1085–91.
71. Zhang HH, Halbleib M, Ahmad F, Manganiello VC, et al. 2002. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 51: 2929–35.
72. Guilherme A, Virbasius JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367–77.
73. Tang X, Guilherme A, Chakladar A, Powelka AM, et al. 2006. An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport. Proc Nat Acad Sci USA 103: 2087–92.
74. Zhang B, Berger J, Hu E, Szalkowski D, et al. 1996. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol Endocrinol 10: 1457–66.
75. Toubal A, Clement K, Fan R, Ancel P, et al. 2013. SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation. J Clinical Invest 123: 362–79.
76. Lo KA, Labadorf A, Kennedy NJ, Han MS, et al. 2013. Analysis of in vitro insulin-resistance models and their physiological relevance to in vivo diet-induced adipose insulin resistance. Cell Reports 5: 259–70.
77. Rzucidlo EM, Martin KA, Powell RJ. 2007. Regulation of vascular smooth muscle cell differentiation. J Vascular Surg 45: A25–32.
78. Loft A, Schmidt SF, Mandrup S. 2015. Modulating the genomic programming of adipocytes. Cold Spring Harb Symp Quant Biol. doi:10.1101/sqb.2015.80.027516
79. Siersbaek R, Rabiee A, Nielsen R, Sidoli S, et al. 2014. Transcription factor cooperativity in early adipogenic hotspots and super-enhancers. Cell reports 7: 1443–55.